Showing results (81-90 of 281) with videos related to
Sort By:
Pageof 29
Expert Opinion on Pharmacotherapy|July 29, 2016
Obeticholic acid for the treatment of primary biliary cholangitisAhmad H Ali, Keith D LindorExpert Opinion on Investigational Drugs|February 16, 2005
Recent advances in the treatment of non-alcoholic fatty liver diseaseFlavia D Mendes, Keith D LindorLiver International : Official Journal of the International Association for the Study of the Liver|September 12, 2007
Development of autoimmune hepatitis in primary biliary cirrhosisAndrea A Gossard, Keith D LindorExpert Opinion on Investigational Drugs|August 25, 2017
Investigational drugs in phase II clinical trials for primary biliary cholangitisMarina G Silveira, Keith D LindorClinics in Liver Disease|September 28, 2018
Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: Is It Really the Same Disease?David M Chascsa, Keith D LindorMinerva Gastroenterologica E Dietologica|June 22, 2019
Cancer risk, screening and surveillance in primary sclerosing cholangitisDavid M Chascsa, Keith D LindorExpert Opinion on Pharmacotherapy|October 26, 2012
Current pharmacotherapy for cholestatic liver diseaseElizabeth J Carey, Keith D LindorHepatology (Baltimore, Md.)|March 5, 2004
Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trialKeith D Lindor, Kris V Kowdley, E Jenny Heathcote, et al.American Journal of Therapeutics|September 23, 2009
Antibiotics for the treatment of primary sclerosing cholangitisDiaa Aldin H Elfaki, Keith D LindorPageof 29